Revenue - Ocumension Therapeutics (HKEX:1477) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 6.77 HKD -1.6%

Updated:

Ocumension Therapeutics
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Ocumension Therapeutics
Revenue Peer Comparison

H

3692

600436

600276

000538

S

688506

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Ocumension Therapeutics HKEX:1477	Revenue ¥246.4m	CAGR 3-Years 166%	CAGR 5-Years N/A	CAGR 10-Years N/A
H	Hansoh Pharmaceutical Group Company Ltd HKEX:3692	Revenue ¥10.1B	CAGR 3-Years 5%	CAGR 5-Years 6%	CAGR 10-Years N/A
	Zhangzhou Pientzehuang Pharmaceutical Co Ltd SSE:600436	Revenue ¥10.6B	CAGR 3-Years 16%	CAGR 5-Years 16%	CAGR 10-Years 22%
	Jiangsu Hengrui Pharmaceuticals Co Ltd SSE:600276	Revenue ¥23.3B	CAGR 3-Years -7%	CAGR 5-Years 5%	CAGR 10-Years 14%
	Yunnan Baiyao Group Co Ltd SZSE:000538	Revenue ¥39.4B	CAGR 3-Years 4%	CAGR 5-Years 7%	CAGR 10-Years 9%
S	Sichuan Biokin Pharmaceutical Co Ltd SSE:688506	Revenue ¥561.9m	CAGR 3-Years -18%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Ocumension Therapeutics's Revenue amounts to 246.4m CNY.

Over the last year, the Revenue growth was 55%. The average annual Revenue growth rates for Ocumension Therapeutics have been 166% over the past three years .

Join more than 146,200+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.